Search - tctmd.com

Displaying 101 - 120 of 129

Sort: Relevancy | Date

News Daily News

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

L.A. McKeown

April 22, 2014

News Conference News ACC 2014

ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients

Caitlin E. Cox

April 02, 2014

News Daily News

Apixaban es Rentable comparado con Warfarina o Aspirina

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

Presentation TCT 2013

Aspirin Dead, Warfarin Still Alive

Presenter: Kristen Patton

October 29, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Daily News

PFO Increases Stroke Risk After Endovascular Device Lead Implantation

August 30, 2013

News Daily News

El FOP Aumenta el Riesgo de ACV tras la Implantación de los Electrodos del Dispositivo Endovascular

August 30, 2013

News Daily News

Después de un accidente cerebrovascular menor/AIT, la terapia antiplaquetaria doble reduce el accidente cerebrovascular recurrente en comparación con la aspirina

July 24, 2013

News Daily News

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

July 24, 2013

Presentation

Clopidogrel with Aspirin in Acute Minor Stroke or TIA

Presenter: Yongjun Wang

June 26, 2013

News Daily News

Stroke After STEMI Unusual But Carries Poor Prognosis

Yael L. Maxwell

May 03, 2013

News Daily News

Population-Based Study Fails to Link PFOs to Increased Risk of CV Events

L.A. McKeown

May 03, 2013

News Daily News

Los ACV tras un cuadro de STEMI son Raros pero tienen Mal Pronóstico

Yael L. Maxwell

May 03, 2013

News Daily News

Estudio demográfico no asocia los PFO al aumento del riesgo de episodios cerebrovasculares

L.A. McKeown

May 03, 2013

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Caitlin E. Cox

July 12, 2012

News Daily News

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Caitlin E. Cox

July 12, 2012

Presentation

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Presenter: S. Lee

July 11, 2012

News Daily News

PLATO Substudy: ACS Patients with Prior Stroke at No Disadvantage with Ticagrelor

Yael L. Maxwell

June 01, 2012

News Daily News

Subestudio PLATO: Los Pacientes con SCA y Antecedentes de ACV no están en Desventaja con el Ticagrelor

Yael L. Maxwell

June 01, 2012

Advertisement

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients

Apixaban es Rentable comparado con Warfarina o Aspirina

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Aspirin Dead, Warfarin Still Alive

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

PFO Increases Stroke Risk After Endovascular Device Lead Implantation

El FOP Aumenta el Riesgo de ACV tras la Implantación de los Electrodos del Dispositivo Endovascular

Después de un accidente cerebrovascular menor/AIT, la terapia antiplaquetaria doble reduce el accidente cerebrovascular recurrente en comparación con la aspirina

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

Clopidogrel with Aspirin in Acute Minor Stroke or TIA

Stroke After STEMI Unusual But Carries Poor Prognosis

Population-Based Study Fails to Link PFOs to Increased Risk of CV Events

Los ACV tras un cuadro de STEMI son Raros pero tienen Mal Pronóstico

Estudio demográfico no asocia los PFO al aumento del riesgo de episodios cerebrovasculares

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

PLATO Substudy: ACS Patients with Prior Stroke at No Disadvantage with Ticagrelor

Subestudio PLATO: Los Pacientes con SCA y Antecedentes de ACV no están en Desventaja con el Ticagrelor

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content